Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4272081 | The Journal of Sexual Medicine | 2010 | 17 Pages |
Abstract
Nebivolol in vivo activated the NO/cGMP pathway, enhanced erectile response and reversed ED in diabetic rats. Moreover, nebivolol in vitro potentiated NO/cGMP-mediated relaxation of human erectile tissues. These effects may account for the low incidence of ED in nebivolol-treated hypertensive patients. Nebivolol therefore may have utility in the treatment of ED, particularly ED associated with diabetes. Angulo J, Wright HM, Cuevas P, González-Corrochano R, Fernández A, Cuevas B, La Fuente JM, Gupta S, and de Tejada IS. Nebivolol dilates human penile arteries and reverses erectile dysfunction in diabetic rats through enhancement of nitric oxide signaling.
Related Topics
Health Sciences
Medicine and Dentistry
Urology
Authors
Javier PhD, Harold M. PhD, Pedro MD, PhD, RocÃo BSc, Argentina LT, Begoña BSc, José M. MD, PhD, Sandeep PhD, Iñigo MD,